We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Access Device for Pancreatic Pseudocyst Drainage

By HospiMedica International staff writers
Posted on 02 Aug 2012
A novel exchange-free device simplifies pancreatic pseudocyst drainage and reduces the number of necessary devices, while ensuring access is not lost during the procedure. More...


The NAVIX Access Device was specifically designed and indicated for pancreatic pseudocyst access and tract dilation, and replaces the use of devices that were not intended for this purpose. The system includes an endoscopic trocar that creates an initial incision into the pseudocyst, an anchor balloon that secures access within the pseudocyst, and a dilation balloon that expands the access tract to 10 mm diameter. The device was designed to address the existing challenges with endoscopic transmural pseudocyst drainage, a procedure that is technically challenging and requires multiple device exchanges.

The device enables exchange-free access, tract dilation, and the placement of up to two guidewires into the pseudocyst, which can be used to deploy one or more drainage stents (guidewires and stents not included). The NAVIX handle is ergonomically designed and allows the interventional endoscopist to deploy the device using a single hand. The NAVIX may also be used to create an access tract for placement of the proprietary AXIOS Stent, a drainage stent specifically indicated for transmural pancreatic pseudocyst drainage. The NAVIX Access Device and the AXIOS Stent are products of Xlumena (Mountain View, CA, USA), and have received the European community CE marking.

“Interventional endoscopists are in need of innovative tools to enable lesser invasive endoscopic treatments of diseases that have been treated surgically in the past,” said Kenneth Binmoeller, MD, director of Interventional Endoscopy Services at California Pacific Medical Center (San Francisco, CA, USA). “Xlumena is meeting this need with efficient, reliable solutions. The NAVIX Access Device and the AXIOS Stent are examples of the type of tools that will fundamentally change the way therapy is delivered and improve patient care.”

A pancreatic pseudocyst is a fluid-filled sac in the abdomen, which may also contain tissue from the pancreas, pancreatic enzymes, and blood. Endoscopic transmural pseudocyst drainage is a technically challenging, cumbersome procedure that normally requires multiple device exchanges in a “trial and error” approach using different tools, during which pseudocyst access can be lost.

Related Links:

Xlumena
California Pacific Medical Center



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.